Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Yttrium90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

NCT01686880 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT01686880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01686880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Yttrium90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2012
Completion date
January 31, 2015
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver cirrhosis